AzTrials
AzTrials

Commotio CerebriGAIN2NCT04798885

Get Going After concussioN 2.0

A study testing GAIN 2.0 in people with Commotio Cerebri and Mild Traumatic Brain Injury, run by University of Aarhus at 1 site in Denmark.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study tests the promising results of a previous study (GAIN 1.0) in a larger RCT (GAIN 2.0) which takes place in the municipalities of Central Denmark Region where citizens live their daily lives and whose health- and social care systems support citizens who experience persisting PCS. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Commotio Cerebri, Mild Traumatic Brain Injury
What is being tested?
GAIN 2.0
Could I receive a placebo?
No, everyone receives an active treatment
How many people
310 participants
Where
1 siteDenmark
Study dates
12 May 2021to 1 Sep 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Concussion caused by a head trauma according to the diagnostic criteria recommended by WHO. Participants must be referred to the project within two to four months of injury.
  • Age 18 to 60 years at the time of the trauma
  • A RPQ score ≥20.
  • Able to understand, speak and read Danish.
  • Living in Central Denmark Region.

Who cannot join

  • Objective neurological findings and/or acute trauma CT scan indicating neurological disease or brain damage.
  • Previous concussion leading to persistent PCS within the last two years.
  • Severe misuse of alcohol, prescription drugs and/or illegal drugs.
  • Psychiatric morbidity or severe neurological disease that impedes participation in the program, i.e. Bipolar Disorder, autism, psychotic disorder (life time), multiple sclerosis etc.

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Regionshospitalet Hammel Neurocenter

    Hammel, 8450

Other trials in Denmark

About this study

Official title: Interdisciplinary Intervention for Patients With Post-concussion Symptoms 3-6 Months Post-injury (GAIN 2.0). A Stepped Wedge Cluster Randomised Trial: Effect on Symptoms, Participation in Daily Activities, and Labour Market Attachment

The study tests the promising results of a previous study (GAIN 1.0) in a larger RCT (GAIN 2.0) which takes place in the municipalities of Central Denmark Region where citizens live their daily lives and whose health- and social care systems support citizens who experience persisting PCS.

Read the detailed description

Concussion, the mildest form of traumatic brain injury, is an important public health concern. Recent studies estimate that persistent post-concussion symptoms (PCS) are present in almost half of the affected citizens at one year post-injury. Prospective studies have demonstrated that these citizens are at risk of developing long-lasting symptoms which are associated with high societal burden due to long-term impact on labour market attachment and increased use of health care and social benefits. In Denmark, there has in recent years been an increasing awareness on societal impact and personal consequences of PCS. Accordingly, clinicians as well as social workers and therapists in the municipalities point to the gab in knowledge concerning PCS and advocate urgently for evidence-based treatment for these citizens. Recently, the research group behind this application developed a novel early intervention - "Get going After concussIoN" (GAIN 1.0) - for citizens who experience persistent PCS three to six months post-concussion. The intervention was tested in a randomized controlled trial (RCT) with promising results. However, it was delivered in a single hospital setting in which these citizens are normally not cared for. In this study the intention is to test the results of GAIN 1.0 in a larger RCT (GAIN 2.0) which takes place in the municipalities of Central Denmark Region where citizens live their daily lives and whose health- and social care systems support citizens who experience persisting PCS.

Being tested
GAIN 2.0
Medical subject headings
Brain Concussion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • GAIN 2.0Behavioural

    1. three structured group sessions of two hours duration performed jointly by a neuropsychologist, an occupational therapist and a physiotherapist. Relatives are also invited. 2) Up to five weekly semi-structured individual sessions of 30 min. duration with an allocated therapist
Study groups in NCT04798885
Study groupRoleWhat they receive
Enhanced usual careNo interventionParticipants will be informed about typical Post Concussion Symptoms and the process of typical recovery as well as given reassurance concerning the prognosis. Advice concerning the use of pain relief medication will also be provided.
GAIN 2.0 interventionExperimentalAn eight-week, interdisciplinary intervention program based on principles from cognitive behavioural therapy (CBT) and gradual return to activities.
Receives: Behavioral: GAIN 2.0

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change of at least seven in the sum score on the Rivermead Post-Concussion Symptoms Questionnaire (RPQ)

    RPQ is a self-report scale to measure the severity of Post Concussion Symptoms covering physical, cognitive, and emotional symptoms with 16 sub-items and a total sum score (range 0-64, higher score define more severe status)

    Measured: Three months after end of treatment

Secondary outcomes (9)
  1. Sumscore in the dimension 'time spend on daily activities' on the Utrecht Scale for Evaluation of Rehabilitation-Participation (USER-P).

    Utrecht Scale for Evaluation of Rehabilitation-Participation is a generic measurement that both objectively and subjectively measure participation in Instrumental Activities of Daily Living (IADL) such as work, voluntary work, education, family duties and responsibilities, leisure activities, transportation, communication and social activities in three dimensions. The sumscore in each dimension is converted to a 0-100 metric with higher scores meaning af better outcome.

    Measured: Three months after end of treatment

  2. Sumscore in the dimension 'limitations' on the Utrecht Scale for Evaluation of Rehabilitation-Participation (USER-P)

    Utrecht Scale for Evaluation of Rehabilitation-Participation is a generic measurement that both objectively and subjectively measure participation in Instrumental Activities of Daily Living (IADL) such as work, voluntary work, education, family duties and responsibilities, leisure activities, transportation, communication and social activities in three dimensions.The sumscore in each dimension is converted to a 0-100 metric with higher scores meaning af better outcome.

    Measured: Three months after end of treatment

  3. Sumscore in the dimension 'satisfaction with participation' on the Utrecht Scale for Evaluation of Rehabilitation-Participation (USER-P)

    Utrecht Scale for Evaluation of Rehabilitation-Participation is a generic measurement that both objectively and subjectively measure participation in Instrumental Activities of Daily Living (IADL) such as work, voluntary work, education, family duties and responsibilities, leisure activities, transportation, communication and social activities in three dimensions.The sumscore in each dimension is converted to a 0-100 metric with higher scores meaning af better outcome.

    Measured: Three months after end of treatment

  4. Long term sick leave defined as public assistance benefits related to illness in more than three consecutive weeks

    Calculated based on weekly public assistance benefits extracted from the DREAM register

    Measured: Within 12 months after concussion

  5. Cumulated incidence proportion of participants on long term sick leave defined as receiving public assistance benefits related to illness in more than three consecutive weeks

    Calculated based on weekly public assistance benefits extracted from the DREAM register

    Measured: Within 36 months after concussion

  6. Proportion of employed participants defined as receiving no public assistance benefits except from state education fund grants

    Calculated based on weekly public assistance benefits extracted from the DREAM register

    Measured: At 12 months after concussion

  7. Proportion of employed participants defined as receiving no public assistance benefits except from state education fund grants

    Calculated based on weekly public assistance benefits extracted from the DREAM register

    Measured: At 36 months after concussion

  8. Degree of job stability based on whether labor market contributions have been paid

    Monthly measure extracted from the DREAM register

    Measured: At 12 months after concussion

  9. Degree of job stability based on whether labor market contributions have been paid

    Monthly measure extracted from the DREAM register

    Measured: At 36 months after concussion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Mar 2021
  2. Study start12 May 2021
  3. Primary completion1 Jun 2023
  4. Study completion1 Sep 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
310 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04798885
Sponsor's protocol ID
GAIN 2.0
Acronym
GAIN2
Status last verified
Nov 2023
First submitted
9 Mar 2021
Last updated
13 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Hellemose LA, Thastum MM, Stabel HH, Odgaard L, Rask CU, Silverberg ND, Skandsen T, Rytter HM, Nygaard C, Eggertsen PP, Pedersen CB, Nielsen JF. Interdisciplinary intervention (GAIN) vs. enhanced usual care for reducing severe post-concussion symptoms in adults 2-4 months post-injury: a stepped wedge cluster randomised controlled trial. EClinicalMedicine. 2026 Sep 22;100:104243. doi: 10.1016/j.eclinm.2026.104243. eCollection 2026 Oct.

    PubMed 42891011
  • Naess-Schmidt ET, Thastum MM, Stabel HH, Odgaard L, Pedersen AR, Rask CU, Silverberg ND, Schroder A, Nielsen JF. Interdisciplinary intervention (GAIN) for adults with post-concussion symptoms: a study protocol for a stepped-wedge cluster randomised trial. Trials. 2022 Jul 29;23(1):613. doi: 10.1186/s13063-022-06572-7.

    PubMed 35906645

Questions about this trial

What is this clinical trial studying?

A study testing GAIN 2.0 in people with Commotio Cerebri and Mild Traumatic Brain Injury, run by University of Aarhus at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change of at least seven in the sum score on the Rivermead Post-Concussion Symptoms Questionnaire (RPQ) (time frame: Three months after end of treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04798885, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Nov 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in